Delivra™ Announces Completion of an Analytical Skin Absorption Study for LivRelief Topical Pain Relief Cream

Published: Aug 01, 2012

BURLINGTON, Ontario--(BUSINESS WIRE)--Delivra™, the Canadian-based biotechnology company and market leader in transdermal delivery technology, announces the results of clinical trials on its patented delivra system and LivRelief Topical Pain Relief Cream. According to the findings, delivra™ technology is not only the first to successfully deliver a water-soluble molecule beneath the skin in significant concentrations, but it also penetrates healing ingredients 687% deeper into the dermis and muscle than the ingredients used in the leading topical pain relief creams.

Back to news